Page last updated: 2024-10-28

hydroxyurea and Neuroendocrine Tumors

hydroxyurea has been researched along with Neuroendocrine Tumors in 2 studies

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research Excerpts

ExcerptRelevanceReference
" The purpose of the current study was to determine whether dose intensification of parenteral hydroxyurea in combination with fluorouracil could enhance the response rates of the combination against refractory upper gastrointestinal malignancies."6.71Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors. ( Haynes, H; Kaleya, R; Kaubisch, A; Rozenblit, A; Wadler, S, 2004)
" The purpose of the current study was to determine whether dose intensification of parenteral hydroxyurea in combination with fluorouracil could enhance the response rates of the combination against refractory upper gastrointestinal malignancies."2.71Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors. ( Haynes, H; Kaleya, R; Kaubisch, A; Rozenblit, A; Wadler, S, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaubisch, A1
Kaleya, R1
Haynes, H1
Rozenblit, A1
Wadler, S1
Tanaka, T1
Shimizu, N1

Trials

1 trial available for hydroxyurea and Neuroendocrine Tumors

ArticleYear
Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; F

2004

Other Studies

1 other study available for hydroxyurea and Neuroendocrine Tumors

ArticleYear
Induced detachment of acentric chromatin from mitotic chromosomes leads to their cytoplasmic localization at G(1) and the micronucleation by lamin reorganization at S phase.
    Journal of cell science, 2000, Volume: 113 ( Pt 4)

    Topics: Chromatin; Chromosomes; Cytoplasm; DNA Replication; G1 Phase; Humans; Hydroxyurea; Lamins; Micronucl

2000